Smoking Cessation Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Therapy (Nicotine Replacement Therapy, Non-Nicotine Replacement Therapy), By Product Type (Chewing Gum, Patches, Sprays And Inhalers, E-cigarettes, Others), And By Geography - Forecasts From 2019 To 2024

  • Published : May 2021
  • Report Code : KSI061612286
  • Pages : 114
The smoking cessation market is projected to grow at a CAGR of 14.86% to reach US$42.247 billion by 2024, from US$18.402 billion in 2018. Excessive intake of tobacco/nicotine can lead to tobacco or nicotine dependence causing severe health problems. Thus, quitting smoking helps in reducing the risks of developing smoking-related diseases.
Treatment for tobacco or nicotine dependence requires repeated treatments which include medication and counselling. At present, the number of former smokers outweighs the current smokers. Hence, a high prevalence of smokers requires treatments related to smoking cessation, thus, fuelling the market growth in the forecast period. The United States from the North American region is expected to show a significant market share due to a high prevalence of smokers here. Furthermore, growing health awareness will provide an opportunity for the smoking cessation market to thrive during the forecast period and beyond.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the smoking cessation value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the smoking cessation market.
Major industry players profiled as part of the report are GSK group of companies, Dr. Reddy’s Laboratories Ltd., Cipla Inc., and Chrono Therapeutics Inc. among others.

Smoking Cessation Market Scope:

Report Metric Details
 Market size value in 2018  US$18.402 billion
 Market size value in 2024  US$42.247 billion
 Growth Rate  CAGR of 14.86% from 2018 to 2024
 Base year  2018
 Forecast period  2019–2024
 Forecast Unit (Value)  USD Billion
 Segments covered  Therapy, Product Type, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered  GSK Group of Companies, Dr. Reddy’s Laboratories Ltd., Cipla Inc., Chrono   Therapeutics Inc., Invion Limited, Selecta Biosciences, Inc., Achieve Life Sciences,   Inc., Lotus, Ethismos Research Inc.
 Customization scope  Free report customization with purchase
The smoking cessation market has been analyzed through the following segments:
By Therapy
Nicotine Replacement Therapy
Non-Nicotine Replacement Therapy
By Product Type
Chewing Gum
Sprays and Inhalers
By Geography
North America
South America
United Kingdom
Middle East and Africa
Saudi Arabia
Asia Pacific
South Korea

Frequently Asked Questions (FAQs)

Q1. What are the growth prospects for smoking cessation market?
A1. The smoking cessation market is projected to grow at a CAGR of 14.86% during the forecast period.
Q2. What will be the smoking cessation market size by 2024?
A2. The smoking cessation market is projected to reach a total market size of US$42.247 billion by 2024.
Q3. What is the size of global smoking cessation market?
A3. Smoking Cessation market was valued at US$18.402 billion in 2018. 
Q4. What factors are anticipated to drive the smoking cessation market growth?
A4. The high prevalence of smokers requires treatments related to smoking cessation, thus, fuelling the market growth in the forecast period. 
Q5. Which region holds the largest market share in the smoking cessation market?
A5. The United States from the North American region is expected to show a significant share in the smoking cessation market due to a high prevalence of smokers here. 

1. Introduction
1.1. Market Overview
1.2. Market Definition
1.3. Scope Of The Study
1.4. Currency
1.5. Assumptions
1.6. Base, And Forecast Years Timeline
2. Research Methodology  
2.1. Research Design
2.2. Secondary Sources
3. Executive Summary
4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. Smoking Cessation Market By Therapy
5.1. Nicotine Replacement Therapy
5.2. Non-Nicotine Replacement Therapy
6. Smoking Cessation Market By Product Type
6.1. Chewing Gum
6.2. Patches
6.3. Sprays And Inhalers
6.4. E-Cigarettes
6.5. Others
7. Smoking Cessation Market By Geography
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East And Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others
8. Competitive Intelligence
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments And Deals
8.3. Strategies of Key Players
9. Company Profiles
9.1. GSK Group of Companies
9.2. Dr. Reddy’s Laboratories Ltd.
9.3. Cipla Inc.
9.4. Chrono Therapeutics Inc.
9.5. Invion Limited
9.6. Selecta Biosciences, Inc.
9.7. Achieve Life Sciences, Inc.
9.8. Lotus
9.9. Ethismos Research Inc.

GSK Group of Companies
Dr. Reddy’s Laboratories Ltd.
Cipla Inc.
Chrono Therapeutics Inc.
Invion Limited
Selecta Biosciences, Inc.
Achieve Life Sciences, Inc.
Ethismos Research Inc.